Ginkgo Bioworks Holdings, Inc. DNA NYSE

Ginkgo Bioworks Holdings, Inc. (DNA) reported total assets of $1.12B and total liabilities of $611.11M for quarter ending 2025-12-31, resulting in total equity of $508.59M.

The company held $422.62M in cash and short-term investments. Total debt stood at $417.08M, with net debt of $249.88M. The Debt-to-Equity (D/E) ratio was 0.82 (moderate).

Current ratio is 4.92, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (75/100, Pass) — Debt-to-Equity of 0.82, current ratio of 4.92 — balance sheet is strong
• MOAT (58/100) — Total assets $1.12B and equity $508.59M support the company's competitive scale
• VALUE (79/100) — Debt-to-Equity 0.82 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 45/100 with 2/7 criteria passed.